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of 11α-hydroxyprogesterone and ethanol using 
recombinant yeast expressing fungal steroid 
hydroxylases
Claire M. Hull1, Andrew G. S. Warrilow1, Nicola J. Rolley1, Claire L. Price1, Iain S. Donnison2, Diane E. Kelly1* 
and Steven L. Kelly1* 
Abstract 
Background: Bioethanol production from sustainable sources of biomass that limit effect on food production are 
needed and in a biorefinery approach co-products are desirable, obtained from both the plant material and from the 
microbial biomass. Fungal biotransformation of steroids was among the first industrial biotransformations allowing 
corticosteroid production. In this work, the potential of yeast to produce intermediates needed in corticosteroid pro-
duction is demonstrated at laboratory scale following bioethanol production from perennial ryegrass juice.
Results: Genes encoding the 11α-steroid hydroxylase enzymes from Aspergillus ochraceus (11α-SHAoch) and Rhizopus 
oryzae (CYP509C12) transformed into Saccharomyces cerevisiae for heterologous constitutive expression in p425TEF. 
Both recombinant yeasts (AH22:p11α-SHAoch and AH22:p509C12) exhibited efficient progesterone bioconversion 
(on glucose minimal medial containing 300 µM progesterone) producing either 11α-hydroxyprogesterone as the 
sole metabolite (AH22:p11α-SHAoch) or a 7:1 mixture of 11α-hydroxyprogesterone and 6β-hydroxyprogesterone 
(AH22:p509C12). Ethanol yields for AH22:p11α-SHAoch and AH22:p509C12 were comparable resulting in ≥75% conver-
sion of glucose to alcohol. Co-production of bioethanol together with efficient production of the 11-OH intermediate 
for corticosteroid manufacture was then demonstrated using perennial ryegrass juice. Integration of the 11α-SHAoch 
gene into the yeast genome (AH22:11α-SHAoch+K) resulted in a 36% reduction in yield of 11α-hydroxyprogesterone 
to 174 µmol/L using 300 µM progesterone. However, increasing progesterone concentration to 955 µM and optimiz-
ing growth conditions increased 11α-hydroxyprogesterone production to 592 µmol/L product formed.
Conclusions: The progesterone 11α-steroid hydroxylases from A. ochraceus and R. oryzae, both monooxygenase 
enzymes of the cytochrome P450 superfamily, have been functionally expressed in S. cerevisiae. It appears that these 
activities in fungi are not associated with a conserved family of cytochromes P450. The activity of the A. ochraceous 
enzyme was important as the specificity of the biotransformation yielded just the 11-OH product needed for corticos-
teroid production. The data presented demonstrate how recombinant yeast could find application in rural biorefinery 
processes where co-production of value-added products (11α-hydroxyprogesterone and ethanol) from novel feed-
stocks is an emergent and attractive possibility.
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Background
Biofuels such as bioethanol are a key focus for sustaina-
bility away from fossil fuels and in a biorefinery approach 
maximum value and product extraction is envisaged. 
For instance, plant protein or other products may be 
extracted prior to fermentation of carbohydrates. The 
microbial biomass also offers routes to co-products. 
Some of the first industrial biotransformations involved 
filamentous fungi for production of key intermediates 
in corticosteroid production that were hard to achieve 
by chemical synthesis. Ever since the first study report-
ing microbial 11α-hydroxylation of progesterone using 
Rhizopus arrhizus over 60  years ago [1], there has been 
sustained scientific and commercial interest in the appli-
cation of bacteria [2–6] and filamentous fungi [7–9] to 
produce hydroxylated pharmaceuticals and intermedi-
ates. Structural hydroxylations are often necessary to 
functionalize steroid-based drugs that exhibit higher effi-
cacy than their non-hydroxy analogs [10], and the ability 
to perform regio- and stereo-specific modifications using 
whole-cell microbial biocatalysis is invaluable for large-
scale steroid manufacturing [11] not least because certain 
hydroxylations can prove difficult or even impossible to 
achieve via synthetic chemistry.
Unlike unicellular yeasts, filamentous fungi (e.g., Rhiz-
opus, Aspergillus, and Mucor spp.) can hydroxylate the 
sterane skeleton (Fig. 1) at numerous positions (1β, 2β, 4, 
5α, 6β, 7α, 7β, 9α, 10β, 11α, 11β, 12α, 12β, 14, 15α, 15β, 
16α, 17α, 19, 22, 26) [12]. Alpha and beta hydroxylations 
at carbon 11 have for more than 50 years been performed 
commercially using filamentous fungi [11] and are par-
ticularly desirable for the synthesis of the glucocorticoid 
steroids that are commonly prescribed as anti-inflamma-
tory, immunosuppressive, anti-allergic, and contraceptive 
drugs [13]. However, despite their industrial and biomed-
ical value, species-specific information about 11α-steroid 
hydroxylases from filamentous fungi and data regard-
ing their prevalence across the fungal kingdom remains 
limited; instead they are classified very broadly as 
monooxygenase enzymes of the cytochrome P450 (CYP) 
superfamily. In fact, sequencing data for just two fungal 
11α-steroid hydroxylases from Aspergillus ochraceus [14] 
and Rhizopus oryzae [15] are currently available. Follow-
ing historical neglect, it is hoped that the recent establish-
ment of fungal genome databases and increasing interest 
in transcriptional data for filamentous species will now 
permit new biotechnological approaches that will har-
ness the full biosynthetic potential of fungal cytochrome 
Fig. 1 Steroid chemical structure. a Gonane, the steroid nucleus comprising three cyclohexane rings (rings A, B, and C) and one cyclopentane (ring 
D) labeled using the IUPAC-recommended ring-lettering and atom-numbering. b Hydroxylation of progesterone to 11α-hydroxyprogesterone
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P450 enzymes [16]. Filamentous fungal genomes can 
contain 100–200 cytochrome P450 genes, representing a 
large potential reservoir of biocatalysts.
It has long been known that the efficiency of using 
certain filamentous fungi (e.g., Aspergillus fumigatus) 
for steroid biotransformations can be compromised by 
the production of unwanted side-product steroids [9, 
17], and there is much interest in the scope to optimize 
and apply recombinant yeast as ‘microbial cell facto-
ries’ in order to achieve specific hydroxylations [10, 13, 
16]. Recombinant strains of the fission yeast Schizosac-
charomyces pombe have been employed for steroid bio-
conversions [18] including the 11α-hydroxylation of 
progesterone [15]. Designer strains of Saccharomyces 
cerevisiae that express mammalian steroid hydroxylases 
involved in xenobiotic metabolism (e.g., CYP3A4) have 
also been reported [19] that are capable of synthesizing 
hydrocortisone from glucose [20]. The scope of microbial 
biotechnology continues to expand and it is increasingly 
well recognized that the production of bio-based chemi-
cals and biofuels from non-food carbohydrate feedstock 
using metabolically engineered yeast could offer a sus-
tainable alternative to their petroleum-based production 
[21]. The application of recombinant yeast to assist the 
process development that is needed to overcome chal-
lenges in manufacturing and pharmaceutical industries 
has also been highlighted [22].
In the present study, we sought to develop a recombi-
nant strain of S. cerevisiae that could hydroxylate proges-
terone at carbon 11α (Fig. 1) and that could be applied to 
the rural biorefinery concept [23] to achieve co-produc-
tion of 11α-hydroxyprogesterone and bioethanol from 
grass juice feedstock [24]. We have previously shown 
that S. pombe, like S. cerevisiae cannot perform steroid 
hydroxylation in its native state [25] and it remains an 
attractive yeast host for heterologous protein expression. 
However, we chose to extend our work with S. cerevi-
siae [24, 26] because it is already employed in large-scale 
ethanol fermentations and because commercial and 
research ventures continue to yield more robust strains 
that are able to tolerate industrial conditions [21]. Grass 
juice sourced from Lolium perenne (ryegrass) represents 
one of several fractions of non-food plant biomass that 
are currently under investigation as feedstock for rural 
biorefinery and bio-based production processes in the 
United Kingdom [27–29]. It is rich in water-soluble car-
bohydrates (fructans, fructose, glucose, and sucrose) and 
its potential to support yeast growth and ethanol produc-
tion has already been demonstrated [24, 26]. Therefore, 
producing a strain of S. cerevisiae that can produce both 
11α-hydroxyprogesterone and ethanol using grass juice 
as carbon source can increase the financial yield from the 
bioconversion. As the global market for pharmaceutical 
steroid productions stands at around 10 billion USD 
[30] and the total cost of bioethanol is continually falling 
[31], using an integrative approach to coproduce a high-
value platform chemical can increase the profitability of 
bioethanol production and agriculture.
Results from this study are the first to demonstrate 
functional expression of the 11α-steroid hydroxylase 
enzyme, documented for A. ochraceus [14], in S. cerevi-
siae grown on grass juice feedstock. This underscores 
the potential to diversify the scope of the rural biorefin-
ery concept through application of yeast biotechnology, 
which represents an emergent and valuable asset for 
industries of the low-carbon and green economy.
Results
Recombinant yeast: progesterone bioconversion
Metabolite profiles for yeast transformants grown on 
YM+His with 300  μM progesterone indicate that the 
optimized gene sequences encode functional proteins 
that were constitutively expressed and conferred proges-
terone hydroxylating capabilities on AH22:p11α-SHAoch 
and AH22:pCYP509C12 yeast (Table  1; Fig.  2). During 
initial growth experiments with YM+His with 300  μM 
progesterone, almost total bioconversion of progesterone 
was achieved with AH22:p11α-SHAoch which produced 
≥90% 11α-hydroxyprogesterone as the sole metabolite 
after 48  h of growth (Table  1). AH22:pCYP509C12 also 
produced 11α-hydroxyprogesterone, but with lower effi-
ciency (47.61  ±  1.7%; t48h) and lower purity as detect-
able quantities of 6β-hydroxyprogesterone (6.85 ± 1.7%; 
t48h), identified from fragmentation spectra contain-
ing a prominent fragment ion at m/z 346 (Fig. 3e), were 
present in ethyl acetate extracts recovered from cell-
free AH22:pCYP509C12 culture supernatant. Control 
(AH22:p425TEFCtrl) yeast harboring empty p425TEF vec-
tor did not hydroxylate exogenous progesterone (Fig. 2), 
and only progesterone (Fig.  3a) or its trimethylsilyl 
(TMS) derivative (Fig.  3b) was detected in ethyl acetate 
extracts from AH22:p425TEFCtrl culture supernatant.
Recombinant yeast: growth and ethanol fermentation
In studies undertaken using the Bioscreen C plate reader 
with starting (t0h) inoculums of 5  ×  105 cells/mL and 
YM+His media (without progesterone supplementa-
tion), the growth parameters for AH22:p11α-SHAoch, 
AH22:pCYP509C12, and AH22:p425TEFCtrl yeast were 
comparable (Table  2; Fig.  4). All constructs achieved 
similar final population densities (1.61 and 2.1  ×  108 
cells/mL) and exhibited uniform doubling times (typi-
cally 4–5 h) at room temperature (20 ± 2 °C). There were 
no significant differences between the ethanol yields 
recorded for AH22:p11α-SHAoch, AH22:pCYP509C12, 
and AH22:p425TEFCtrl grown on YM+His (ANOVA, 
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P  <  0.05, n =  3). All produced at least 16  mg/mL etha-
nol after 72  h fermentation; this equates to 78% of the 
theoretical maximum (20.4  mg/mL) for 4% glucose. In 
contrast, supplementation of YM+His with 300  µM 
progesterone had an inhibitory effect on the growth 
of AH22:p425TEFCtrl cultures which exhibited slower 
population doubling times (9–10  h), reached lower 
population densities (1.6 × 108 cells/mL), and produced 
lower, more variable amounts of ethanol (12.5 ± 3.2 mg/
mL) than those grown in the absence of progester-
one (Table  2). Progesterone supplementation had no 
effect on the growth profiles or ethanol productiv-
ity of AH22:p11α-SHAoch or AH22:pCYP509C12 yeast 
(Table  2). In view of their bioconversion efficiency and 
11α-hydroxyprogesterone specificity, only AH22:p11α-
SHAoch yeast was selected for subsequent process optimi-
zation studies.
Two‑step (bioconversion–fermentation) batch culture 
studies
For AH22:p11α-SHAoch yeast (Fig.  5), complete proges-
terone bioconversion to 11α-hydroxyprogesterone was 
achieved after just 8 h when cultures were agitated con-
tinuously at 200  rpm at 20  °C. Following progesterone 
bioconversion (Step 1), decreasing the shaking regime 
from 200 to 30 rpm (at t10h) was found to support opti-
mal ethanol production of 18 ± 2 mg/mL (Fig. 5b) which 
was 88% of the theoretical maximum ethanol yield attain-
able with 4% glucose and 10% higher than that achieved 
in Bioscreen studies. In summary, the use of higher t0h 
inoculums (1 ×  108 cells/mL) and vigorous culture agi-
tation (200  rpm) facilitated progesterone bioconversion 
(Step 1). The higher cell densities (typically ≥3  ×  108 
cells/mL) present by t10h and lower agitation speeds 
(30 rpm) employed during fermentation (Step 2) resulted 
in higher ethanol yields.
A biorefinery application for recombinant 
AH22:p11α‑SHAoch
Complete bioconversion of progesterone to 
11α-hydroxyprogesterone (Step 1) was achieved within 
8 h when either grass juice with progesterone or 7% glu-
cose YM+His with progesterone was used as feedstock 
for AH22:p11α-SHAoch yeast maintained at 20  ±  2  °C 
with vigorous shaking (200  rpm). As expected, ethyl 
acetate extraction of 11α-hydroxyprogesterone from the 
grass juice supernatant at the end (t10h) of the bioconver-
sion step (Fig.  6) resulted in the recovery of numerous 
phyto-chemicals that were identified using GC–MS (data 
not shown). The most abundant of these were 1-hexacos-
anol, phytol, α-tocopherol, 1-tetracosanol, 1-octacosanol, 
campesterol, stigmasterol, and β-sitosterol. Following 
resuspension of the AH22:p11α-SHAoch cell pellet in fresh 
feedstock (without progesterone supplementation) and 
Table 1 GC–MS parameters and diagnostic ions for progesterone (Pg) substrate and hydroxylated (hydroxyPg) products
Steroid (%) abundances are mean values from three replicates with associated standard deviations
TMS trimethylsilyl derivatized, RT retention time, [M]+ mass ion
Peak Gas chromatography–mass spectrometry: steroid identification Steroid: % total (t48h)
Steroid RT (min) [M]+ Fragment ions m/z (relative 
intensity)
AH22:p425TEFCtrl AH22:p11α‑SHAoch AH22:pCYP509C12
a Progesterone (Pg) 21.04 314 43 (999) 124 (887) 314 (701) 
272 (430) 229 (362)
91 (329) 41 (314) 79 (313) 22 
(238) 67 (234)
100 9.90 (±1.2) 45.54 (±3.1)
b Pg + TMS (×1) 20.36 386 386 (999) 73 (820) 43 (365) 387 
(311) 371 (145)
75 (141) 209 (132) 208 (118) 91 
(101) 196 (97)
c 11α-hydroxyPg + TMS 
(×2)
21.61 474 73 (999) 474 (559) 43 (230) 192 
(227) 475 (219)
75 (198) 193 (126) 208 (85) 74 
(84) 476 (80)
0 90.10 (±1.6) 47.61 (±1.7)
d 11α-hydroxyPg + TMS 
(×1)
23.29 402 73 (999) 43 (825) 75 (395) 402 
(347) 91 (310)
312 (277) 197 (260) 143 (253) 
169 (233) 105 (223)
e 6β-hydroxyPg + TMS (×1) 21.40 402 73 (999) 43 (906) 346 (712) 75 
(688) 91 (386)
387 (347) 79 (295) 93 (262) 402 
(240) 119 (226)
0 0 6.85 (±1.7)
Maximum % bioconversion (ΣhydroxyPg) 0.00 91.70 57.86
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after decreasing the culture agitation speed to 30 rpm for 
fermentation (Step 2), the maximum ethanol yields pro-
duced by AH22:p11α-SHAoch yeast on both grass juice 
and 7% glucose YM+His were 30–32  mg/mL. These 
ethanol yields exceed 85% of the theoretical maximum 
(35.7  mg/mL) for 7% glucose (Fig.  6). At the end of the 
studies undertaken using grass juice feedstock, screening 
of yeast cells plated onto selective YM+His agar at the 
end of both Step 1 (bioconversion) and Step 2 (fermenta-
tion) recovered a high percentage (typically ≥95%) of col-
ony forming AH22:p11α-SHAoch yeast that had retained 
the plasmid.
Progesterone bioconversion obtained with 11α‑SHAoch 
integrated into S. cerevisiae clone
To establish whether expression of 11α-SHAoch using the 
p425 plasmid was comparable to integrating the gene, 
an integrated expression cassette, 11α-SHAoch+K, was 
produced. Initial growth experiments in YM+His with 
300 µM progesterone showed that AH22:11α-SHAoch+K 
was able to achieve 58% conversion of progesterone to 
11α-hydroxyprogesterone (174 µmol/L) after 48 h. Con-
trol AH22 cells did not hydroxylate progesterone as no 
steroid metabolites were detected upon extraction with 
ethyl acetate.
To investigate further whether 11α-SHAoch was able to 
metabolize higher concentrations of progesterone, the 
starting concentration was increased from 300 to 954 µM 
(0.3  g/L, in accordance with Žnidaršič et  al. [32]) and 
the ratio of grass juice to YM, the inoculum size, and the 
incubation temperature were varied. Lowering the tem-
perature from 30 to 24 °C increased the bioconversion of 
progesterone to 11α-hydroxyprogesterone from 42–50 to 
54–62% after 48 h (Table 3). Diluting the grass juice with 
YM and using a lower inoculum only marginally affected 
the bioconversion rates. The maximum conversion rate 
obtained using AH22:11α-SHAoch+K of 62% (591 µmol/L) 
was achieved after 48  h at 24  °C with a 1:1 mixture of 
grass juice and yeast minimal media (Table 3). This was 
a 3.4-fold increase in yield of 11α-hydroxyprogesterone 
compared to that obtained using 300  µM progesterone 
as substrate in YM+His and a 2.2-fold increase in yield 
compared to using clone AH22:p11α-SHAoch in YM+His 
after 48 h at 30 °C with 300 µM progesterone (Table 1).
Discussion
In situ hydroxylation of progesterone (Table 1) indicated 
both A. ochraceus 11α-SH and R. oryzae CYP509C12 
were native steroid hydroxylating enzymes. AH22:p11α-
SHAoch (Figs.  2, 3) produced 11α-hydroxyprogesterone 
as the sole product and AH22:pCYP509C12 pro-
duced a 7:1 mixture of 11α-hydroxyprogesterone and 
6β-hydroxyprogesterone (Fig.  5e); A. ochraceus 11α-SH 
and R. oryzae CYP509C12 shared only 15% sequence iden-
tity (82 conserved amino acid residues) along the whole 
length of the two enzymes. However, NCBI BLAST2 
analysis (http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_
TYPE=BlastSearch&PROG_DEF=blastn&BLAST_
PROG_DEF=megaBlast&BLAST_SPEC=blast2seq) 
identified 26% sequence identity (45 amino acid resi-
dues) in a 174 amino acid long region from the C-ter-
mini. The relatively low sequence identity between 
these two CYP enzymes suggests they belong to differ-
ent CYP families. Native complementary DNA (cDNA) 
encoding the A. ochraceus 11α-SH has previously been 
co-expressed with cDNA for human oxidoreductase in 
Fig. 2 GC–MS chromatograms for progesterone substrate and 
hydroxylated metabolites extracted from steroid bioconver-
sion experiments. See Table 1 and Fig. 3 for specific diagnostic 
and mass ion information. a Progesterone, b TMS-derivatized 
Progesterone, c diTMS-derivatized 11α-hydroxyprogesterone, d 
TMS-derivatized 11α-hydroxyprogesterone, e TMS-derivatized 
6β-hydroxyprogesterone
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Fig. 3 Fragmentation patterns (electron ionization) for progesterone substrate and hydroxylated metabolites. a Progesterone; b TMS-
derivatized progesterone; c diTMS-derivatized 11α-hydroxyprogesterone; d TMS-derivatized 11α-hydroxyprogesterone; e TMS-derivatized 
6β-hydroxyprogesterone. (TMS = trimethylsilyl derivatized)
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Spodoptera frugiperda (Sf-9) insect cells [14]. Similarly, 
cDNA encoding the R. oryzae CYP509C12 has also been 
co-expressed with its native redox partner (R. oryzae 
NAD[P]H-dependent reductase) in recombinant fis-
sion yeast, S. pombe, which were also able to perform 
11α- and 6β-steroid hydroxylation [15]. It is noteworthy 
that homology modeling and site-directed-mutagenesis 
studies have recently proved successful in redirecting the 
regio-selectivity of CYP106A2 (a mammalian P450 with 
15β-hydroxylase and minor 11α-hydroxylase activity) 
from C15 to C11 [33]. The potential to bioengineer the 
specificity of fungal steroid hydroxylases (e.g., to remove 
the 6β-activity of CYP509C12) also exists and advances 
in this area now demand much better understanding 
of the catalytic and structural features of fungal steroid 
hydroxylases.
The recombinant AH22 (S. cerevisiae) whole-cell sys-
tem reported in the present study extends the scope and 
application of the technological achievements of previ-
ous authors [14, 15] and demonstrates the constitutive 
Table 2 Growth parameters and ethanol yields for recombinant yeast grown on 4%  glcMhis ± Pg
Mean values from three replicates are shown along with the associated standard deviations. Underlined values are significantly lower than those from comparator 
experiments (ANOVA, P < 0.05; n = 3)
Construct ΔOD600 [t48h] Max. population doubling 
time (h)
Density: cells/mL [t72h] Ethanol: mg/mL [t72h]
−Pg +Pg −Pg +Pg −Pg +Pg −Pg +Pg
AH22:p425TEFCtrl 1.61 0.98 4.6 (±0.5) 9.0 (±1.0) 2.1 × 108 1.6 × 108 15.9 (±1.4) 12.5 (±3.2)
AH22:p11α-SHAoch 1.65 1.63 4.3 (±0.5) 4.5 (±0.5) 2.2 × 108 2.1 × 108 16.4 (±1.8) 16.2 (±2.0)
AH22:pCYP509C12 1.61 1.62 4.4 (±0.5) 4.6 (±0.5) 2.0 × 108 2.1 × 108 16.5 (±1.5) 16.0 (±1.1)
Fig. 4 Growth profiles and ethanol yields. Growth profiles and ethanol yields for AH22:p11α-SHAoch (●), AH22:pCYP509C12 (◊), and 
AH22:p425TEFCtrl (◯) yeast grown on YM+His (a, c) or YM+His + 300 μM progesterone (b, d). Mean values of three replicates along with associ-
ated standard deviations are shown. The broken lines indicate maximum theoretical ethanol yield for 4% glucose
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expression of functional 11α-steroid hydroxylating 
enzymes in Brewer’s yeast. We chose to focus on the 
application of AH22:p11α-SHAoch yeast after preliminary 
metabolite studies as this biotransformation was highly 
specific and active. The maximum bioconversion initially 
achieved using AH22:p11α-SHAoch yeast and 300 µM pro-
gesterone was very high (90.9% 11α-hydroxyprogesterone 
or 273 µmol/L) and did not require heterologous electron 
donors to cytochrome P450 such as NADPH cytochrome 
P450 reductase (Table  1). The inhibitory effect of exog-
enous progesterone on the growth and ethanol yields of 
AH22:p425TEFCtrl (Table  2; Fig.  4) was consistent with 
the effect of steroid toxicity on S. cerevisiae [34]. The 
growth rates and ethanol yields for AH22:p11α-SHAoch 
and AH22:pCYP509C12 grown on YM+His with or 
without progesterone were comparable suggesting that 
constitutive expression of A. ochraceus 11α-SH and R. 
oryzae CYP509C12 served a protective role in recombi-
nant AH22:p11α-SHAoch and AH22:pCYP509C12 yeast. 
The ability of Aspergillus and Rhizopus spp. to hydroxy-
late and excrete steroids represents one mechanism 
through which filamentous species are believed to detox-
ify and so persist when exposed to steroids or similar 
molecules [35].
By increasing the starting inocula from 5  ×  105 to 
1  ×  108 cells/mL in optimization studies undertaken 
with AH22:p11α-SHAoch yeast (Fig.  5) and through ini-
tial application of vigorous culture agitation (Step 1: 
bioconversion, 200  rpm), we achieved 100% conversion 
of progesterone to 11α-hydroxyprogesterone in just 8 h. 
Fig. 5 Optimized production of 11α-hydroxyprogesterone and 
ethanol using AH22:p11α-SHAoch yeast grown in batch culture with 
YM+His and 300 μM progesterone. Three shaker speeds, 30 (◆), 100 
(□), 150 (●), and 200 (◊) rpm, were used. The arrow indicates the 
time point (t10h) at which the speed of AH22:p11α-SH
Aoch cultures 
maintained at 200 rpm (optimal for progesterone bioconversion) a 
was either held at 200 rpm or decreased to 150, 100, or 30 rpm dur-
ing the ethanol fermentation step (b). Mean values of three replicates 
along with associated standard deviations are shown
Fig. 6 Preliminary biorefinery studies. These were performed using 
AH22:p11α-SHAoch yeast and synthetic 7% glucose YM+His (◆) or 
enzyme pretreated grass juice (◊) feedstock. The arrow indicates the 
time point (t10h) at which AH22:p11α-SH
Aoch cultures were pelleted 
and resuspended in fresh feedstock. Broken line indicates maximum 
theoretical ethanol yield for 7% glucose. Mean values of three repli-
cates along with associated standard deviations are shown
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Here, it is likely that increased oxygenation of the cul-
ture medium favored the growth of AH22:p11α-SHAoch 
yeast and facilitated the catalytic activity of constitutively 
expressed A. ochraceus 11α-SH monooxygenase. During 
fermentation (Step 2), the presence of higher cell densi-
ties (≥3  ×  108 cells/mL) and the reduction of culture 
agitation speeds from 200 to 30  rpm (Fig.  5) improved 
the ethanol yields from 78% (Bioscreen studies) to 88%. 
These results reflect a reduction in the amount of glucose 
used for growth under semi-anaerobic conditions and an 
increase in the fermentation of glucose to ethanol; this is 
further evidenced by the lower ethanol yields recorded 
during fermentation (Step 2) regimes (100, 150 and 
200 rpm) that increased the oxygenation of AH22:p11α-
SHAoch cultures (Fig. 5).
Agriculturally sourced grass juice feedstock was ame-
nable to the two-step bioconversion–fermentation pro-
cess developed using AH22:p11α-SHAoch yeast (Fig.  6) 
presenting bioengineering opportunities within biorefin-
ery settings in temperate regions [27–29]. Firstly, it is sig-
nificant that high product (11α-hydroxyprogesterone and 
ethanol) yields were achievable using grass juice feed-
stock at room temperature (20 ± 2 °C). On an industrial 
scale, this could help reduce the need for energy-inten-
sive heating and cooling regimes. Secondly, the solvent 
extraction of 11α-hydroxyprogesterone product from 
the grass juice/progesterone feedstock resulted in the 
recovery of numerous phyto-chemicals including 1-hex-
acosanol, 1-tetracosanol, 1-octacosanol (all commer-
cially relevant fatty alcohols), phytol and α-tocopherol 
(both vitamin E precursors with applications in cosmet-
ics, detergents, and as antioxidants), and campesterol, 
stigmasterol, and β-sitosterol (plant sterols with dietary 
health benefits). Commercial interest in high-value 
phyto-chemicals [23] strengthens the premise for using 
grass juice and other plant-based substrates as feedstock 
for progesterone bioconversion and the development of 
technologies that can optimize the recovery (extraction, 
separation, and purification) of multiple desirable prod-
ucts is an emergent and necessary area of research [36].
Further efforts towards yield optimization were 
focused on the production of the high-value platform 
chemical 11α-hydroxyprogesterone by the 11α-steroid 
hydroxylase enzyme from A. ochraceus. The enzyme 
was integrated into the S. cerevisiae genome to facili-
tate clone stability (no risk of losing the enzyme through 
plasmid loss over time). Increasing the progesterone 
concentration from 300 to 954  µM and reducing the 
incubation temperature from 30 to 24 °C resulted in 2.2-
fold greater bioconversion to 11α-hydroxyprogesterone 
than obtained using the yeast strain containing the ster-
oid hydroxylase on a plasmid (AH22:p11α-SHAoch). The 
increased yield of product at lower temperature reduces 
the external energy requirements and therefore increases 
the cost effectiveness of the bioconversion of progester-
one to 11α-hydroxyprogesterone. A. ochraceus steroid 
11α-hydroxylase was also regiospecific, only hydroxylat-
ing progesterone at the 11α- position, unlike R. oryzae 
steroid hydroxylase which hydroxylated progesterone 
at two positions (11α- and 6β-). Therefore, the use of A. 
ochraceus steroid 11α-hydroxylase would be the more 
economical as further expense to separate hydroxy-
progesterone isomers would not be required. However, 
further optimization is still required before process 
scale-up can take place [22]. High ethanol yields (14.9% 
v/v) have recently been achieved using pure inulin and 
soybean feedstock and an engineered yeast strain (Sac-
charomyces sp. W0) that expresses the inulinase gene 
from Pichia guilliermondii [37]. The use of grass juice 
feedstock extracted from high sugar varieties of ryegrass 
[29] and/or alternative (e.g., flocculating) host strains of 
S. cerevisiae that exhibit enhanced ethanol production 
[38] remains to be investigated. The influence of other 
factors including nutrient supplements, temperature, pH 
stress, and culture volume on ethanol yields from grass 
juice warrants investigation and the use of chemostat and 
bioreactor platforms represents the next step for research 
development [39].
In light of the successful bioconversion of progesterone 
to 11α-hydroxyprogesterone by AH22:11α-SHAoch+K, 
stable, genome-integrated designer yeasts that are able 
to exploit specific feedstocks for the co-production of 
high-value products provide an important avenue for 
commercial biotransformations of chemicals. For exam-
ple, yeasts could be utilized for the production of dietary 
Table 3 Bioconversion of  progesterone to  11α- 
hydroxyprogesterone with AH22:11α-SHAoch+K
Progesterone bioconversion rates obtained using the integrated clone 
AH22:11α-SHAoch+K with 0.3 mg/mL (954 µM) progesterone in growth media 
after 48 h
Grass juice: 
yeast minimal
Inoculum 
(cells/mL)
Temperature 
(°C)
% product 
formed (µmol/L)
1:0 1 × 107 30 47 (448)
1:0 1 × 107 24 54 (515)
1:0 1 × 105 30 44 (420)
1:0 1 × 105 24 58 (553)
1:1 1 × 107 30 44 (420)
1:1 1 × 107 24 58 (553)
1:1 1 × 105 30 44 (420)
1:1 1 × 105 24 62 (591)
1:3 1 × 107 30 42 (401)
1:3 1 × 107 24 59 (563)
1:3 1 × 105 30 50 (477)
1:3 1 × 105 24 60 (572)
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mycoprotein, other myco-products (e.g., sterols, fatty 
acids, minerals, and B-complex vitamins), and specific 
platform chemicals (e.g., vitamin precursors, NADPH, 
and other cofactors required for growth) and opportuni-
ties for the development of industrial scale biotechnology 
exist here.
Conclusions
This study explored the potential for biotransforma-
tion for co-products to add value to a biofuel produc-
tion process using a novel feedstock. Production of a 
key intermediate of corticosteroid production using 
fungal enzymes was demonstrated, a biotransformation 
of historical interest among biotransformations. Fur-
ther biotransformations can be envisaged using the yeast 
biomass involved in bioethanol production as well as 
recovery of useful cellular components of yeast from the 
fermentation.
Methods
Sequence optimization
Genes encoding A. ochraceus 11α-steroid hydroxylase 
(11α-SHAoch) (Genbank accession number ABH71415.1) 
[14] and R. oryzae CYP509C12 (Genbank accession num-
ber RO3G_05077.1) [15] were designed with codon bias 
optimized for S. cerevisiae and the following modifica-
tions: (i) an AAA triplet (Kozak sequence) upstream of 
ATG initiation codons, (ii) external NotI single restric-
tion sites (for the excision of whole fragments), and (iii) 
flanking BamHI and XhoI single restriction sites for the 
double-digest and direct ligation of genes into p425TEF 
(Dualsystems Biotech), a shuttle vector [ampicillin selec-
tion (bacteria) and LEU2 auxotrophic marker (yeast)], 
that enables constitutive expression driven by the tran-
scription elongation factor (TEF1) promoter [40]. Both 
genes were synthesized commercially (Eurofins MWG 
Operon) and supplied in pEX-K vector (kanamycin selec-
tion) for maintenance in Escherichia coli.
Plasmid construction and recombinant yeast
Optimized genes for A. ochraceus and R. oryzae were 
excised from pEX-K and ligated into pre-cut (BamHI, 
XhoI) p425TEF vector. The resulting plasmids (p11α-
SHAoch and pCYP509C12, respectively) were transformed 
into E. coli strain DH5α (Novagen) that were selected 
and maintained at 37  °C using Luria–Bertani medium 
supplemented with sodium ampicillin (100 mg/L). Puri-
fied p11α-SHAoch and pCYP509C12 plasmid DNA were 
isolated from E. coli cultures (Wizard Plus SV Mini-
preps, Promega) and transformed into S. cerevisiae strain 
AH22 (MATa, leu2-3, 112 his4-519 can1) via electropo-
ration to yield the experimental constructs AH22:p11α-
SHAoch and AH22:pCYP509C12. A control construct 
(AH22:p425TEFCtrl) was created by transforming AH22 
with p425TEF vector. All AH22 yeast transformants were 
selected and maintained at 30  °C using glucose-based 
yeast minimal (YM+His) plates containing (w/v) 2% aga-
rose, 1.34% yeast nitrogen base without amino acids, 4% 
glucose, and l-histidine (100 mg/L).
Progesterone conversion
AH22:p11α-SHAoch, AH22:pCYP509C12, and 
AH22:p425TEFCtrl transformants were screened for their 
ability to convert progesterone into hydroxylated prod-
ucts by inoculating 60 mL volumes of YM+His + 300 µM 
progesterone with single colonies (n = 3) taken directly 
from transformation plates. Cells were grown in 100-mL 
flasks (30 ± 2 °C, 200 rpm) and harvested by centrifuga-
tion (4000  rpm, 5  min) after 48  h. Residual progester-
one substrate and hydroxyprogesterone products were 
extracted from 5 mL volumes of cell-free culture super-
natant with 3  ×  2  mL volumes of ethyl acetate which 
were pooled and evaporated to dryness using a centrifu-
gal evaporator (Heto Maxi dry plus). Extracts were stored 
at −20  °C prior to further analysis. Fresh 100  mM pro-
gesterone stocks (31.4 mg progesterone dissolved in 1 mL 
DMSO) were used to prepare YM+His +  300  μM pro-
gesterone for all experimental work.
Gas chromatography–mass spectrometry (GC–MS) 
metabolite analysis
Prior to GC–MS analysis, steroid extracts were heated 
(70  °C, 10  min) to ensure complete dryness and deri-
vatized using 100  µL N,O-bis(trimethylsilyl)trifluoro-
acetamide-trimethylchlorosilane (BSTFA-TMCS 
[99:1]) and 100  µL anhydrous pyridine heated at 70  °C 
for 2  h [41]. Trimethylsilyl (TMS)-derivatized sterols 
were analyzed using a 7890A GC–MS system (Agi-
lent Technologies) with a DB-5MS fused silica column 
(30  m ×  0.25  mm ×  0.25  µm film thickness; J&W Sci-
entific). The oven temperature was initially held at 70 °C 
for 4 min, and then increased at 25 °C/min to a final tem-
perature of 280 °C, which was held for a further 25 min. 
Samples were analyzed in splitless mode (1 µL injection 
volume) using helium carrier gas, electron ionization 
(ion source temperature of 150  °C), and mass scanning 
from m/z 40 to 850 [41]. GC–MS data files were ana-
lyzed using MSD Enhanced ChemStation software 
(Agilent Technologies Inc.) to determine metabolite pro-
files for AH22:p11α-SHAoch, AH22:pCYP509C12, and 
AH22:p425TEFCtrl and for derivation of integrated peak 
areas. Progesterone and hydroxyprogesterone metabo-
lites were identified with reference to retention times 
and mass fragmentation patterns for known standards. 
Phyto-chemicals that were co-extracted from grass juice 
feedstock in ‘Biorefinery pilot studies’ were identified 
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using the NIST Mass Spectral Search Program (NIST/
EPA/NIH Mass Spectral Library, Version 2.0  g, May 
2011) and with reference to diagnostic fragmentation 
spectra.
Growth and ethanol production
Growth rate and ethanol productivity comparisons 
for AH22:p11α-SHAoch, AH22:pCYP509C12, and 
AH22:p425TEFCtrl grown on YM+His with 300  μM 
progesterone were undertaken in 100-well honeycomb 
microplates using a Bioscreen C (Oy Growth Curves Ab 
Ltd., Finland) as previously described [26]. Briefly, uni-
form starting (t0h) culture densities were achieved by 
resuspending single colonies in YM+His (with or with-
out 300 μM progesterone) and diluting to achieve 5 × 105 
cells/mL. Starting cultures were vortexed and dispensed 
into Bioscreen wells (3  ×  300  µL replicates per colony 
suspension). All experiments were incubated at 20 ± 2 °C 
in the Bioscreen (no shaking regime) for 72 h, with opti-
cal density (at 600  nm) readings taken every 45  min. 
Growth data were exported from the Bioscreen in ASCII 
format prior to analysis using Excel (Microsoft Office 
2003).
Growth parameters
In addition to manual (Neubauer haemocytometer) cell 
counts, ΔOD600 values (derived by subtracting the start-
ing optical density from the final reading) were recorded. 
Maximum doubling times were estimated by dividing the 
natural logarithm of 2 by the fastest population growth 
rates (μ) derived using linear trend lines (y  =  mx  +  c, 
where y  =  vertical axis coordinate; m  =  gradient; 
x = horizontal axis coordinate and c = y axis intercept) 
fitted to log-transformed OD data. For ethanol analyses, 
Bioscreen measurements were suspended at specific time 
points (t0h, t24h, t48h, and t72h) and a 10  μL volume of 
culture supernatant removed from representative experi-
mental wells.
Ethanol content
Ethanol content was determined using a spectropho-
tometric ethanol assay kit (K-ETOH 11/06; Megazyme 
Ltd.) according to manufacturer’s instructions. All sam-
ples were diluted 1000-fold with distilled water prior to 
analysis. Ethanol yields were calculated as a percentage of 
the maximal theoretical yield for glucose (0.51 g/g).
Two‑step batch culture studies: optimization of shaking 
regime
Two-step (bioconversion–fermentation) batch culture 
studies were performed at 20 ±  2  °C with AH22:p11α-
SHAoch yeast grown in 100-mL conical flasks containing 
60  mL volumes of YM+His with 300  μM progesterone. 
Step 1 (progesterone bioconversion) experiments were 
initiated with t0h inoculums of 1  ×  108 cells/mL that 
were agitated at speeds of 30, 100, 150, or 200  rpm for 
48  h. One milliliter volumes were aseptically removed 
from experimental flasks at t2h, t4h, t8h, t24h, and t48h 
in order to determine % conversion of progesterone to 
11α-hydroxyprogesterone. Step 2 (ethanol fermentation) 
optimization was pursued using AH22:p11α-SHAoch that 
had been maintained (throughout Step 1) at 200 rpm on 
YM+His with 300 μM progesterone. At t10h, the shaking 
speed of these cultures was decreased to 150, 100, and 
30 rpm or held at 200 rpm for a further 75 h. One mil-
liliter volumes were removed from fermentation cultures 
for the determination of ethanol content at t24h, t48h, t60h, 
and t72h. The theoretical maximum ethanol yield for 4% 
(40  mg/mL) glucose (assuming 0.51  g/g) was calculated 
to be 20.4 mg/mL.
Biorefinery studies using grass juice feedstock
Biorefinery studies were performed using AH22:p11α-
SHAoch yeast and enzyme (Lactobacillus paraca-
sei β-fructosidase) pretreated grass juice comprising 
70 mg/mL monosaccharide [24] or synthetic 7% glucose 
YM+His (containing 70  mg/mL glucose equivalent) as 
feedstock. Grass juice was extracted from ryegrass L. per-
enne supplied by the Institute of Biological, Environmen-
tal Research and Rural Sciences (IBERS, Aberystwyth, 
UK), screened to remove large particulates, autoclaved 
(121 °C, 30 min), and pretreated with purified L. paraca-
sei β-fructosidase [24] prior to use as a growth and fer-
mentation substrate. Step 1 (progesterone bioconversion) 
was initiated with 60 mL volumes of grass juice + 300 μM 
progesterone or 7% glucose YM+His + 300 μM proges-
terone and t0h inoculums of 1 × 108 cells/mL that were 
maintained in 100-mL conical flasks at 20  ±  2  °C and 
agitated at 200 rpm. After 10 h, AH22:p11α-SHAoch cul-
tures were harvested by centrifugation (4000 rpm, 5 min) 
and metabolites in the cell-free culture supernatant were 
extracted using ethyl acetate for GC–MS analysis. Cell 
pellets were then resuspended in 60 mL volumes of fresh 
grass juice or 7% glucose YM+His (without progester-
one) and maintained for a further 120 h at 20 ± 2 °C and 
at a shaking speed of 30 rpm. One milliliter volumes were 
removed at t24h, t48h, t72h, t96h, and t120h for the determi-
nation of ethanol content. The theoretical maximum eth-
anol yield for 7% (70 mg/mL) glucose (assuming 0.51 g/g) 
was calculated to be 35.7 mg/mL. For studies using grass 
juice feedstock, colony screening of AH22:p11α-SHAoch 
cells (100 µL of a 1 × 103 cells/mL dilution) plated onto 
selective YM+His agar was performed to calculate the 
recovery (%) of yeast that had retained the p11α-SHAoch 
plasmid at the end of Step 1 (bioconversion; t10h) and 
Step 2 (fermentation; t125h).
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Integration of 11α‑SHAoch into the genome of S. cerevisiae
The 11α-SHAoch gene was synthesized (Eurofins MWG 
Operon) with optimization for S. cerevisiae and sup-
plied in the vector pBSII SK(+). Forward and reverse 
PCR primers were prepared to produce a cassette for 
the transformation of S. cerevisiae AH22 cells. Prim-
ers were designed to include PCR priming sites for ends 
of the gene (how many bases?), 50-bp complementary 
sequences upstream of the Ura3 gene and downstream of 
the Ura3 gene, SalI/SpeI restriction sites for insertion of 
the KanMX marker, and NotI sites for excision from the 
plasmid. The PCR cassette was inserted into pBSII SK(+) 
at the NotI site (chosen as it had been altered to remove 
the SalI and SpeI sites) producing pBSII SK(+):11α-
SHAoch+K. Construct integrity was checked by DNA 
sequencing. A KanMX cassette was cut out of pAH3 vec-
tor using SalI–SpeI digest and inserted into the SalI/SpeI 
site of pBSII SK(+):11α-SHAoch+K to give the final trans-
formation cassette. pBSII SK(+):11α-SHAoch+K was 
digested with NotI prior to transformation into chemi-
cally competent AH22 cells. Positive transformants were 
selected using geneticin in YPD and were checked by 
sequencing PCR products produced when using primers 
located upstream and downstream of the Ura3 site, inter-
nal 11α-SHAoch gene primers, and KanMx primers.
The ability of AH22:11α-SHAoch+K to hydroxylate pro-
gesterone was assessed using the methodology described 
above, except bioconversion was also measure when 
954 µM (0.3 g/L) of progesterone was added to YM.
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